Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
eli lilly
europe blog main
europe top stories
life sciences
national blog main
national top stories
abbvie
alkermes
allergan
avapritinib
blueprint medicines
boston
buprenorphine
cancer
cancer drugs
capmatinib
cariprazine
clinical trials
europe
fda
felipe jain
gastrointestinal stromal tumors
genentech
indiana blog main
indiana top stories
jess fiedorowicz
jessica jeffrey
karim calis
life science
lumateperone
m health fairview
marc goodman
massachusetts general hospital
medullary thyroid cancer
national institutes of health (nih)
non-small cell lung cancer
novartis
What
designed
2
×
drug
fda
address
alkermes
antipsychotic
approval
approves
benefits
blueprint
cancer
carries
caveats
certain
commonly
effect
favor
gain
genetic
latest
medicine
medicines
offer
panel
pass
prescribed
psyche
ret
signature
signatures
targeted
targeting
therapy
treatment
vote
weighs
weight
won
Language
unset
Current search:
designed
×
biotech
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
